Molecular pathways and the hope of targeting angiogenesis
- 10 July 2007
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 4 (9) , 470-471
- https://doi.org/10.1038/ncpuro0858
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Signal-transduction inhibitors in renal cell carcinomaBJU International, 2007
- A phase II study of sunitinib administered in a continuous daily regimen in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC)Journal of Clinical Oncology, 2006
- Sunitinib in Patients With Metastatic Renal Cell CarcinomaJAMA, 2006
- Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2006